The Institute for Clinical and Economic Review’s (ICER) final evidence report assessing the clinical effectiveness and economic value of three acute treatments for migraines had more favorable...
The Food and Drug Administration (FDA) recently published a final rule and additional resources to provide useful information to healthcare providers to ensure smooth regulatory transition of insulin...
ICER adopts Aetion’s platform to advance standards for how real-world evidence can inform decision making for clinical trials and enhance overall patient care.
The Institute for Clinical...
Esperion recently announced that the FDA approved Nexletol an LDL-cholesterol lowering medicine, boosting access to medicine for patients with familial hypercholesterolemia or atherosclerotic...
Germany-based pharmaceutical company, Stada, announced it acquired 15 well-established local and regional consumer over-the-counter (OTC) products from GlaxoSmithKline (GSK).
The proposed...
Members of Congress demand accessible, available, and affordable drug pricing for taxpayer-funded coronavirus (COVID-19) vaccines or treatments, according to an official letter from House Democrats to...
With the prevalence of antibiotic resistance rapidly rising, a new study published in Cell is offering a more efficient, cost-efficient strategy for antibiotic discovery using machine learning.
There...
Prescription drug prices continue to increase due to continued growth in medical service costs and a modest uptick in utilization, according to a recent report from the Health Care Cost Institute...
The city of Marietta has filed a class action lawsuit against drug manufacturer Mallinckrodt, claiming the company increased the price for a specific seizure medication by 97,500 percent, according to...
According to a GoodRx analysis, Myalept is the most expensive prescription drug in the US in 2020 with a list price of $72,306.
In their yearly analysis, GoodRx researchers broke down the most...
Biogen recently won an ongoing patent dispute over its multiple sclerosis (MS) drug, Tecfidera, which pulled in nearly $4.4 billion in revenue in 2019, according to a decision from the US Patient and...
Following in Colorado’s footsteps, Illinois became the second state to cap out-of-pocket costs for insulin at $100 for a 30-day supply after Gov. JB Pritzker signed SB 667 into law on January...
The Federal Trade Commission and the New York Attorney General Letitia James filed a complaint in federal court against Vyera Pharmaceuticals, Martin Shkreli and Kevin Mulleady, seeking to ban the...
Reliance on just a select few pharmaceutical companies to carry the fight against the growing public health threat that is antimicrobial resistance could be what is holding back real...
The Government Accountability Office unveiled a report on Tuesday that identifies challenges and opportunities with the use of machine learning throughout the drug development lifecycle.
Machine...
Weakness in the oversight of the 340B Drug Discount Program allowed some hospitals to get discounted drugs they were ineligible for, a Government Accountability Office analysis found.
Hospitals,...
Nearly a quarter of a million providers are using a point-of-care drug price transparency tool and benefits checker when prescribing patients a medication, a considerable step up in recent years,...
The pharmaceutical industry could lose $1 trillion in overall revenue and still remain as one of the most lucrative industries in the country, according to research conducted in partnership between...
Industry experts have come to agree that the traditional method for financing the healthcare system is not working. National healthcare expenditures are accelerating at an unsustainable rate, with...
In October 2018, the Trump administration proposed an international reference pricing model to reduce the federal government's spending on prescription drugs.
The International Pricing Index (IPI)...
